The “double-agent” functions of the FUBP1 gene have been identified in a variety of cancers; for example, genomic loss-of-function mutations are linked with poor survival in oligodendrogliomas, suggesting a tumor-suppressive function of FUBP1 [26]. Here, FUBP1 is linked to neoplasm.